Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Raised by Asset Dedication LLC

Asset Dedication LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 94.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 534 shares of the medical equipment provider’s stock after acquiring an additional 259 shares during the quarter. Asset Dedication LLC’s holdings in Intuitive Surgical were worth $279,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in ISRG. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,843 shares of company stock valued at $15,357,560. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $572.71 on Thursday. The firm has a 50 day simple moving average of $548.70 and a 200 day simple moving average of $507.04. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market cap of $203.99 billion, a P/E ratio of 92.08, a P/E/G ratio of 5.19 and a beta of 1.39.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday. CICC Research assumed coverage on Intuitive Surgical in a report on Monday. They issued a “neutral” rating and a $550.00 target price for the company. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. Finally, Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.